Intuitive Surgical, Inc. $ISRG Stock Bought by Generali Asset Management SPA SGR

Key Points

• Generali Asset Management increased its Intuitive Surgical stake by 15.5% in the third quarter, bringing its holdings to 22,212 shares valued at approximately $9.03 million. Institutional investors collectively own 83.64% of ISRG.
• Intuitive Surgical reported strong quarterly results, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share, beating analysts’ estimates of $2.91 billion and $2.65, respectively.
• Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and an average price target of $493.54, although insider selling and margin pressure remain potential concerns for the richly valued stock.

Generali Asset Management SPA SGR boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 15.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,212 shares of the medical equipment provider's stock after acquiring an additional 2,983 shares during the period. Generali Asset Management SPA SGR's holdings in Intuitive Surgical were worth $9,032,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of ISRG. Bank of America Corp DE lifted its stake in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock worth $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $1,335,753,000. Amundi boosted its holdings in shares of Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Finally, Janus Henderson Group PLC grew its position in shares of Intuitive Surgical by 3.7% in the first quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider's stock valued at $757,489,000 after purchasing an additional 58,587 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In related news, SVP Patricia Wadors sold 1,078 shares of the company's stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company's stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at $464,993.46. This represents a 79.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 38,806 shares of company stock worth $16,824,795. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $444.18 on Thursday. The firm has a market capitalization of $153.97 billion, a price-to-earnings ratio of 53.71, a PEG ratio of 3.12 and a beta of 1.46. The company's 50-day moving average is $399.37 and its two-hundred day moving average is $435.44. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analysts' expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business's revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.40 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. BTIG Research reaffirmed a "buy" rating and issued a $454.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Barclays reissued an "overweight" rating and set a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Mizuho dropped their target price on Intuitive Surgical from $415.00 to $400.00 and set a "neutral" rating for the company in a report on Wednesday, October 21st. Robert W. Baird upped their target price on Intuitive Surgical from $513.00 to $550.00 and gave the company an "outperform" rating in a report on Wednesday, October 21st. Finally, BNP Paribas Exane raised Intuitive Surgical to an "outperform" rating in a research note on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $493.54.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
• Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
• Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
• Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.